| Phase I Study to Evaluate the Pharmacokinetics and Safety After Co-administration of L03RD1 and L03RD2 or Administration of L03TD1 in Healthy Volunteers (NCT07533539) | Celltrion | 2026-05-09 |
| A Bioequivalence Study of CT-L02 Compared to Co-administration (CTL0201 and CTL0202) in Healthy Volunteers (NCT07128654) | Celltrion | 2025-09-17 |
| Study to Compare Pharmacokinetics and Safety of CT-P52 and US-licensed Taltz in Healthy Subjects (NCT07200986) | Celltrion | 2025-09-17 |
| Phase I Study to Evaluate the Pharmacokinetics and Safety After Co-administration of L03RD1 and L03RD2 or Administration of CT-L03 in Healthy Volunteers (NCT07158346) | Celltrion | 2025-08-18 |
| A Study to Compare Pharmacokinetics, Efficacy and Safety of Subcutaneous CT-P44 and Darzalex Faspro in Combination With Lenalidomide and Dexamethasone in Patients With Refractory or Relapsed Multiple Myeloma (NCT06952478) | Celltrion | 2025-08-12 |
| Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin and Metformin (NCT07093476) | Celltrion | 2025-07-18 |
| A Study to Compare the Auto-injector and Pre-filled Syringe of CT-P43 in Healthy Male Subjects (NCT06951828) | Celltrion | 2025-05-30 |
| A Study to Compare Efficacy and Safety of CT-P55 and Cosentyx in Patients With Moderate to Severe Psoriasis (NCT06630559) | Celltrion | 2025-05-26 |
| To Compare the Pharmacokinetics, Safety, and Immunogenicity of Subcutaneous CT-P6 and Herceptin in Healthy Male Subjects (Trastuzumab) (NCT06687928) | Celltrion | 2025-03-26 |
| A Study to Compare Effects and Safety of CT-P51 and Keytruda in Patients With Previously Untreated Metastatic Lung Cancer (NCT06939595) | Celltrion | 2025-01-30 |
| A Phase 3 Study to Evaluate Efficacy & Safety of Subcutaneous CT-P13 in Patients With Moderate to Severe Active Rheumatoid Arthritis (NCT06738719) | Celltrion | 2025-01-03 |
| Efficacy and Safety of Pioglitazone Combination Therapy in Type 2 Diabetes Patients on a Background of Empagliflozin With Metformin (NCT06571591) | Celltrion | 2024-08-27 |
| To Compare the Pharmacokinetics, Safety and Immunogenicity of CT-P55 and Cosentyx in Healthy Subjects (NCT07054970) | Celltrion | 2024-01-12 |
| A Study to Compare Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of CT-P53 and Ocrevus in Patients With Relapsing-remitting Multiple Sclerosis (NCT05906992) | Celltrion | 2024-01-11 |
| A Bioequivalence Study of L04TD3 Compared to Administration of L04RD1 in Healthy Volunteers (NCT05993806) | Celltrion | 2023-06-02 |
| A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P47 in Patients With Active Rheumatoid Arthritis (NCT05725434) | Celltrion | 2023-02-06 |
| A Study to Evaluate the Safety of Remsima® SC in the Treatment of RA, AS, PsA and Ps (NCT05866614) | Celltrion | 2023-01-13 |
| Compare the Auto-injector and Pre-filled Syringe of CT-P47 in Healthy Subjects (NCT05617183) | Celltrion | 2022-11-15 |
| To Compare Pharmacokinetics, Efficacy, and Safety of CT-P17 With Humira in Patients With Moderate to Severe Chronic Plaque Psoriasis (NCT05495568) | Celltrion | 2022-11-07 |
| A Bioequivalence Study of L04TD2 Compared to Administration of L04RD1 in Healthy Volunteers (NCT05581693) | Celltrion | 2022-09-30 |
| A Bioequivalence Study of L04TD1 Compared to Administration of L04RD1 in Healthy Volunteers (NCT05568121) | Celltrion | 2022-09-01 |
| A Food Effect Study of CT-L01 After Oral Administration in Healthy Volunteers (NCT05364164) | Celltrion | 2022-07-09 |
| Study to Evaluate and Compare the Efficacy and Safety of AZM and AML Combined and Alone in Mild-to-moderate Essential Hypertensive Subjects (NCT05385770) | Celltrion | 2022-07-08 |
| A Bioequivalence Study of CT-L01 Compared to Co-administration (ALO 25 mg and MET XR 1,000 mg) in Healthy Volunteers (NCT05363384) | Celltrion | 2022-06-11 |
| To Evaluate the Safety and Efficacy of Inhaled CT-P63 and CT-P66 Combination Therapy in Symptomatic Patients With COVID-19 Not Requiring Supplemental Oxygen (NCT05224856) | Celltrion | 2022-04-01 |
| A Study to Compare the Pharmacokinetics and Safety of CT-P47 and RoActemra in Healthy Subjects (NCT05188378) | Celltrion | 2021-12-22 |
| To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P63 in Healthy Subjects (NCT05017168) | Celltrion | 2021-10-11 |
| A Drug-Drug Interaction Study of CTL0901 and CTL0902 Compared to Coadministration in Healthy Adult Volunteers (NCT05009368) | Celltrion | 2021-07-23 |
| A Drug-Drug Interaction Study of CTL0801 and CTL0802 Compared to Coadministration in Healthy Adult Volunteers (NCT05002244) | Celltrion | 2021-07-23 |
| Study to Compare Efficacy and Safety of CT-P42 in Comparison With Eylea in Patients With Diabetic Macular Edema (NCT04739306) | Celltrion | 2021-07-22 |
| A Phase 3 Study to Compare Between CT-P41 and US-licensed Prolia in Postmenopausal Women With Osteoporosis (NCT04757376) | Celltrion | 2021-06-17 |
| A Study to Compare the Efficacy and Safety of CT-P43 to Stelara in Patients With Plaque Psoriasis (NCT04673786) | Celltrion | 2021-01-11 |
| To Compare Efficacy and Safety of CT-P39 and EU-approved Xolair in Patients With Chronic Spontaneous Urticaria (NCT04426890) | Celltrion | 2020-12-09 |
| A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 in Subjects With Obstructive Hypertrophic Cardiomyopathy (NCT04418297) | Celltrion | 2020-10-23 |
| A Phase I Study to Evaluate the Safety and Pharmacokinetics of CT-P41 and EU-approved Prolia in Healthy Male Subjects (NCT04512872) | Celltrion | 2020-10-20 |
| A Phase 2/3 Study to Evaluate the Efficacy and Safety of CT-P59 in Patients With Mild to Moderate SARS-CoV-2 Infection (NCT04602000) | Celltrion | 2020-10-05 |
| This is a Phase 1 Study to Evaluate the Safety,Tolerability and Virology of CT P59 in Patients With Mild Symptoms of Symptoms of Coronavirus Disease (COVID-19) (NCT04593641) | Celltrion | 2020-09-04 |
| CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Ulcerative Colitis (LIBERTY-UC) (NCT04205643) | Celltrion | 2020-09-01 |
| Study to Compare PK and Safety of Subcutaneous Injection of Ustekinumab and CT-P43 in Healthy Subjects (NCT04428814) | Celltrion | 2020-08-03 |
| To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P59 in Healthy Subjects (NCT04525079) | Celltrion | 2020-07-18 |
| To Compare the PK and Safety of Omalizumab (CT-P39, EU-approved Xolair, and US-licensed Xolair) in Healthy Subjects (NCT04018313) | Celltrion | 2020-05-28 |
| CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Crohn's Disease (LIBERTY-CD) (NCT03945019) | Celltrion | 2019-10-28 |
| A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis (NCT04171414) | Celltrion | 2019-09-09 |
| To Compare the Pharmacokinetics and Safety of CT-P17 and Humira in Healthy Subjects (NCT03970824) | Celltrion | 2019-05-31 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 or CT-G11 and Food Effect of CT-G20 in Human Participants (NCT03918967) | Celltrion | 2019-04-08 |
| To Compare Efficacy and Safety of CT-P16 and European Union-Approved Avastin as First-Line Treatment for Metastatic or Recurrent Non-Squamous Non-Small Cell Lung Cancer (NCT03676192) | Celltrion | 2019-02-01 |
| A Study to Compare Efficacy and Safety of CT-P17 With Humira in Patients With Active Rheumatoid Arthritis (NCT03789292) | Celltrion | 2018-11-26 |
| CT-P13 (Infliximab) Subcutaneous Administration by Pre-filled Syringe and Auto-injector in Healthy Subjects (NCT03446976) | Celltrion | 2018-02-21 |